Ferronova announces preliminary results of MAGMAP, a 62-patient gastric and oesophageal cancer trial investigating lymph node mapping

Data Readoutpositivenanoparticle-based platformPositive

AI Analysis

Summary

Ferronova announced preliminary results from the MAGMAP trial, a 62-patient multi-centre study evaluating a nanoparticle-based platform for lymph node mapping in gastric and oesophageal cancer patients.

Clinical Trial Data

Patients

Outcome Details

Preliminary results from MAGMAP trial announced

Importance:5/10

Sentiment:

0.50

gastric canceroesophageal cancerlymph node mappingnanoparticle technologymedical devicepreliminary results

Related Companies

$MDCE

Read the original article

Published by PR Newswire Biotech on September 16, 2026 4:00 AM

Read Original